Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
39.15
-0.30 (-0.76%)
At close: Jul 2, 2024, 4:00 PM
38.69
-0.46 (-1.17%)
After-hours: Jul 2, 2024, 7:30 PM EDT
Tandem Diabetes Care Revenue
Tandem Diabetes Care had revenue of $770.01M in the twelve months ending March 31, 2024, down -3.11% year-over-year. Revenue in the quarter ending March 31, 2024 was $191.67M with 13.16% year-over-year growth. In the year 2023, Tandem Diabetes Care had annual revenue of $747.72M, a decrease of -6.68%.
Revenue (ttm)
$770.01M
Revenue Growth
-3.11%
P/S Ratio
3.28
Revenue / Employee
$320,837
Employees
2,400
Market Cap
2.53B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
Dec 31, 2020 | 498.83M | 136.53M | 37.68% |
Dec 31, 2019 | 362.31M | 178.44M | 97.05% |
Dec 31, 2018 | 183.87M | 76.27M | 70.88% |
Dec 31, 2017 | 107.60M | 23.35M | 27.72% |
Dec 31, 2016 | 84.25M | 11.40M | 15.65% |
Dec 31, 2015 | 72.85M | 23.13M | 46.51% |
Dec 31, 2014 | 49.72M | 20.72M | 71.41% |
Dec 31, 2013 | 29.01M | 26.53M | 1,072.00% |
Dec 31, 2012 | 2.48M | - | - |
Dec 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.97B |
agilon health | 4.78B |
Progyny | 1.11B |
ACADIA Pharmaceuticals | 813.81M |
ADMA Biologics | 283.18M |
MorphoSys AG | 264.75M |
Rhythm Pharmaceuticals | 91.93M |
Agios Pharmaceuticals | 29.40M |
TNDM News
- 10 days ago - Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions - Business Wire
- 12 days ago - Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer - Business Wire
- 14 days ago - Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association's 84th Scientific Sessions - Business Wire
- 4 weeks ago - Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM - Business Wire
- 5 weeks ago - Tandem Diabetes Care Announces Upcoming Conference Presentation - Business Wire
- 2 months ago - Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance - Business Wire
- 2 months ago - Tandem Diabetes Care Announces Upcoming Conference Presentations - Business Wire
- 3 months ago - Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024 - Business Wire